They analyzed the association between body mass index (weight divided by height) and progression - free survival (PFS) and overall survival (OS) in six independent
cohorts of patients treated with targeted therapy, immunotherapy or chemotherapy in pivotal trials that led to FDA approval of these drugs.
A cohort of patients treated with the immune checkpoint inhibitor ipilimumab (207 patients) showed similar results.
Not exact matches
In
Cohort A, pembrolizumab shrunk tumors by more than 30 percent in eight
of 170
patients, or five percent, and stabilized the disease in 35, or 21 percent,
of those previously
treated for mTNBC.
Adams points out that
Cohort A is the first phase II study of an immunotherapy for triple negative breast cancer to be reported and represents the largest cohort of patients with mTNBC treated with immunotherapy to
Cohort A is the first phase II study
of an immunotherapy for triple negative breast cancer to be reported and represents the largest
cohort of patients with mTNBC treated with immunotherapy to
cohort of patients with mTNBC
treated with immunotherapy to date.
«The
cohort study has found that the sofosbuvir / daclatasvir combination is associated with a high rate
of SVR4 in difficult - to -
treat patients infected by genotype - 1 hepatitis C.
We hope that this helps support further treatment options for difficult - to -
treat patients,» said Professor Stanislas Pol, Hôpital Cochin, Paris, France, principal investigator
of the French ANRS CO-22 Hepather
cohort.
Obese
patients with metastatic melanoma who are
treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology
of 1,918
patients in six independent clinical
cohorts.
Evaluation
of 66
patients with JDM, recruited from the UK JDM
Cohort and Biomarker Study and actively
treated with anti-TNF agents, showed significant improvements in muscle and skin involvement, as well as in overall disease activity.
They used exome sequencing and immunostaining
of DNA damage response proteins in order to evaluate HRR, and findings were then validated in a
cohort of breast cancer
patients with BRCA1 / 2 mutations who were
treated with PARP inhibitors.
One hundred and forty
patients were
treated with CHOP - based chemotherapy in a historical
cohort of Shanghai Ruijin Hospital from 1997 to 2011, and referred to as the training
cohort.
In this retrospective
cohort study — meaning the
patients in the study already had thyroid cancer and were known to have been exposed to the TMI accident — lead researcher Dr. David Goldenberg, professor
of surgery, and colleagues identified 44
patients who were
treated at the Penn State Health Milton S. Hershey Medical Center for the most common type
of thyroid cancer, papillary thyroid cancer, between 1974 and 2014.
Genome - wide association study (GWAS) data from a prospective
cohort of warfarin -
treated patients (n = 711) was also analyzed for genetic variations across the CYP4F gene cluster.
Known and novel independent prognostic markers were identified in our
cohort of proteasome inhibitor and IMiD -
treated patients with long follow - up, including events with context - specific prognostic value, such as deletions
of the PRDM1 gene.
Based on an analysis
of bowel symptoms recorded using the Gastrointestinal Symptom Rating Scale, researchers reported that despite the use
of a gluten free diet — universally indicated for coeliac disease (CD)-- a proportion
of their
cohort still presented with «persistent symptoms» and it is within this
cohort they were aiming to see whether: «abnormal intestinal microbiota may be associated with persisting gastrointestinal symptoms in
treated celiac disease
patients... [found] higher relative abundance
of Proteobacteria and a lower abundance
of Bacteroidetes and Firmicutes.»